FIGURE 5.

ADAR3 expression is elevated in a majority of glioblastoma patient tumors. A, lysates from glioblastoma tissue (Tumor) and matched adjacent brain tissue (Adj.) were subjected to SDS-PAGE and immunoblotting for ADAR3. Actin is the loading control. B, percentage of mRNAs edited at the Q/R site of GRIA2 in glioblastoma tissue and matched adjacent brain tissue from six glioblastoma patients. C, lysates from glioblastoma tissue (Tumor) and matched adjacent brain tissue (Adj.) were subjected to SDS-PAGE and immunoblotting for ADAR2.